Hetero Labs Limited Oseltamivir Export Data — India (DGFT 2022–2026)

Name: Hetero Labs Limited Oseltamivir Export Records India — #2 Exporter, 240 Shipments, $12.0M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Oseltamivir

India Pharmaceutical Trade Intelligence

$122.6M118 Suppliers79 CountriesHS 30049099

ExportsIndia → UNITED STATES59.0%India → CHINA10.7%

ImportsBULGARIA → India$39.0K UNITED STATES → India$21.6K

#1 Supplier: NATCO PHARMA #1 Buyer: EVERSANA LIFE

Hetero Labs Limited — Oseltamivir Exporter #2 | $12.0M Trade Value | TransData Nexus | TransData Nexus

Hetero Labs Limited — Oseltamivir Exporter Profile

Indian Pharmaceutical Exporter · #2 for Oseltamivir · $12.0M export value · DGFT Verified

Hetero Labs Limited is the #2 Indian exporter of Oseltamivir with $12.0M in export value and 240 verified shipments. Hetero Labs Limited holds a 9.8% market share in Oseltamivir exports across 24 countries. The company exports 46 pharmaceutical products worth $319.3M across 18 therapeutic categories.

Hetero Labs Limited — Oseltamivir Export Profile: Buyers & Destinations

Hetero Labs Limited Oseltamivir export treemap — buyers and destination countries | TransData Nexus

Where Does Hetero Labs Limited Export Oseltamivir?

Country	Value	Shipments	Share
UNITED STATES	$3.4M	84	43.9%
CHINA	$1.5M	39	19.5%
KAZAKISTAN	$693.8K	30	8.9%
OMAN	$358.6K	11	4.6%
MEXICO	$348.7K

Who Are the Top Buyers of Oseltamivir from Hetero Labs Limited?

Buyer	Country	Value	Orders
TO THE ORDER OF	UNITED STATES	$4.0M	114
TO THE ORDER OF....	UNITED STATES	$363.0K	10
TO THE ORDER OF.,	CHINA	$323.1K	18
GREENPINE PHARMA GROUP CO.,LTD.	CHINA	$300.0K	6
IBN SINA PHARMACY LLC	OMAN	$203.9K	7
TO THE ORDER	CHINA	$203.1K	5
GREENPINE PHARMA GROUP CO., LTD	CHINA	$175.8K	4
TO THE ORDER OF :	UNITED STATES	$150.0K	3
AMAROX UKRAINE LIMITED,LLC	UKRAINE	$147.6K	3
CAMBER PHARMA LLP, KAZAKHSTAN	KAZAKISTAN	$144.4K	5

Hetero Labs Limited supplies Oseltamivir to 46 buyers globally. The largest buyer is TO THE ORDER OF (UNITED STATES), followed by TO THE ORDER OF.... (UNITED STATES) and TO THE ORDER OF., (CHINA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Oseltamivir Formulations Does Hetero Labs Limited Export?

Product Description / Formulation	Value	Shipments
FLUVIR OSELTAMIVIR PHOSPHATE CAPSULE	$688.1K	23
OSELTAMIVIR 75MG CAPS (76410x10's PACK)	$450.0K	9
OSELTAMIVIR 75MG CAPS (76275x10's PACK)	$300.0K	6
OSELTAMIVIR PHOSPHATE CAPSULES 75MG (OSELVIR), PACKAGE 10 CAPSULES/BLISTER	$300.0K	6
OSELTAMIVIR PHOSPHATE 75MG CAPSULE	$250.0K	5
OSELTAMIVIR 75MG CAPS (75600x10's PACK)	$200.0K	4
FLUVIR OSELTAMIVIR PHOSPHATE CAPSULENOS	$168.7K	12
FLUVIR OSELTAMIVIR PHOSPHATE 75MG CAPSULE 10S	$163.0K	6
OSELTAMIVIR PHOSPHATE CAPSULE 10S	$159.3K	8
OSELTAMIVIR PHOSPHATE CAPSULE	$155.5K	6

Hetero Labs Limited exports 126 distinct Oseltamivir formulations including tablets, capsules, syrups, and combination drugs. The top formulation is FLUVIR OSELTAMIVIR PHOSPHATE CAPSULE with 23 shipments worth $688.1K.

How Does Hetero Labs Limited Compare to Nearest Oseltamivir Exporters?

Exporters ranked immediately above and below #2 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
3	MSN LABORATORIES PRIVATE LIMITED	$12.3M	245	10	$50.0K
2	HETERO LABS LIMITED ★	$12.0M	240	24	$50.0K
5	LUPIN LIMITED	$9.0M	184	4	$48.8K
1	NATCO PHARMA LIMITED	$8.8M	176	7	$50.0K

Hetero Labs Limited ranks #2 among 118 Indian Oseltamivir exporters. Average shipment value of $50.0K compared to the market average of $525.7K. The closest competitors by value are MSN LABORATORIES PRIVATE LIMITED and LUPIN LIMITED.

Which Indian Ports Ship Oseltamivir Exports?

Port	Shipments	% Share
SAHAR AIR CARGO ACC (INBOM4)	348	16.2%
CHENNAI AIR CARGO ACC (INMAA4)	201	9.4%
HYDERABAD ACC (INHYD4)	182	8.5%
SAHAR AIR	151	7.0%
HYDERABAD ICD (INSNF6)	129	6.0%
CHENNAI AIR	125	5.8%
HYDERABAD ICD	119	5.5%
HYDERABAD AIR	108	5.0%

Geopolitical & Trade Policy Impact on Hetero Labs Limited's Oseltamivir Exports

The current geopolitical climate presents both challenges and opportunities for Hetero Labs Limited. The Israel-Iran tensions have led to increased risks in the Red Sea shipping routes, prompting major shipping lines to implement 'Emergency Risk Surcharges' ranging from $250 to $500 per TEU. This escalation in shipping costs directly impacts Indian pharmaceutical exporters like Hetero, potentially eroding profit margins and necessitating strategic adjustments in logistics and pricing strategies.

Conversely, the U.S.-China trade tensions have created openings for Indian pharmaceutical companies. The U.S. has imposed tariffs as high as 245% on APIs from certain countries, leading to a reshoring of pharmaceutical manufacturing. Indian firms, including Hetero, have responded by investing in U.S. facilities, with outbound foreign direct investment estimated between $500-700 million during the partial FY 2025-26. This strategic move not only circumvents tariffs but also strengthens Hetero's presence in the lucrative U.S. market.

The recent India-European Union Free Trade Agreement (FTA), concluded in January 2026, eliminates tariffs on Indian pharmaceuticals entering the EU. This development enhances Hetero's competitiveness in the European market, providing a significant boost to its export potential. However, compliance with the EU's Falsified Medicines Directive remains imperative, necessitating stringent quality controls and traceability measures to maintain market access.

Hetero Labs Limited — Regulatory Compliance & Quality Standards

Regulatory compliance is paramount for Hetero's sustained success in international markets. In October 2025, the U.S. Food and Drug Administration (FDA) issued a Form 483 to Hetero's Nakkapalli facility in Andhra Pradesh, citing six major compliance lapses, including quality control deficiencies and improper documentation practices. Such observations can jeopardize Hetero's ability to supply APIs and antiretroviral drugs to the U.S. market, underscoring the critical need for rigorous adherence to Good Manufacturing Practices (GMP) and prompt corrective actions to address regulatory concerns.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Oseltamivir shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Hetero Labs Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 240 individual customs records matching Hetero Labs Limited exporting Oseltamivir, covering 126 formulations to 26 countries via 46 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 79+ countries, 314+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Oseltamivir

Oseltamivir

Hetero Labs Limited — Oseltamivir Exporter Profile

Hetero Labs Limited — Oseltamivir Export Profile: Buyers & Destinations

Where Does Hetero Labs Limited Export Oseltamivir?

Who Are the Top Buyers of Oseltamivir from Hetero Labs Limited?

What Is India's Total Oseltamivir Export Value and How Much Does Hetero Labs Limited Contribute?

What Is the Average Shipment Value for Hetero Labs Limited's Oseltamivir Exports?

How Does Hetero Labs Limited Compare to Other Indian Oseltamivir Exporters?

What Oseltamivir Formulations Does Hetero Labs Limited Export?

Regulatory Requirements: Exporting Oseltamivir to Key Markets

United States — FDA

How Does Hetero Labs Limited Compare to Nearest Oseltamivir Exporters?

Which Indian Ports Ship Oseltamivir Exports?

What Other Antivirals Products Does Hetero Labs Limited Export?

Geopolitical & Trade Policy Impact on Hetero Labs Limited's Oseltamivir Exports

Hetero Labs Limited — Regulatory Compliance & Quality Standards

About Hetero Labs Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Oseltamivir Export Data from Hetero Labs Limited

Oseltamivir Stats

Company Overview

Top Products by Hetero Labs Limited

Related Analysis

Need Detailed Export Data?

Data Source